PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 31, 2024Journal of Sleep Medicine5 citationsOpen Access

The Intricacies of Insomnia: A Comprehensive Exploration

View Full Paper
NKNimit KharaAAAnagha ApteYVYagnang Vyas

Key Points

Key points are not available for this paper at this time.

Abstract

Insomnia is a pervasive and often debilitating sleep disorder that profoundly affects health and overall wellbeing. This comprehensive review focuses on the historical context, clinical significance, diagnostic criteria, investigative methods, and global treatment guidelines for insomnia. Historically, references to insomnia have appeared in ancient Egyptian and Greek texts, but it was not until the 19th century that they were rigorously studied and classified. Notable individuals, including Vincent van Gogh, Franz Kafka, and Marilyn Monroe, have struggled publicly with insomnia, underscoring its widespread nature. The pathophysiology of insomnia is multifactorial, involving physiological, psychological, and environmental factors. Hyperarousal, dysregulation of the sleep-wake cycle, and neurotransmitter imbalances are central to its development. Insomnia can be categorized into acute, chronic, comorbid, idiopathic, and behavioral types. Epidemiological studies have revealed that up to 30% of adults experience insomnia, with a higher prevalence among women, older adults, and those with a lower socioeconomic status. Insomnia is associated with adverse health outcomes, including cardiovascular diseases, metabolic disorders, cognitive impairment, and increased mortality risk. The COVID-19 pandemic has exacerbated insomnia owing to stress and lifestyle changes. Diagnosis involves a comprehensive assessment, including sleep history, physical examination, and objective evaluations, such as polysomnography. Treatment combines pharmacological and non-pharmacological interventions with cognitive behavioral therapy for insomnia as the first-line approach. Pharmacotherapy includes benzodiazepines, non-benzodiazepine hypnotics, antidepressants, melatonin, and orexin receptor antagonists. Guidelines from the American Academy of Sleep Medicine and the European Sleep Research Society emphasize individualized, evidence-based treatment plans to improve sleep quality and overall health.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Khara et al. (2024) studied this question.

synapsesocial.com/papers/68e5a18bb6db64358753c84bhttps://doi.org/10.13078/jsm.240014
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Comprehensive Approach to Diagnosis and Management of Insomnia: An Integrative Review with a Focus on Healthcare Perspectives2025
  2. 2Insomnia Epidemic: How Poor Sleeping Habits Are Undermining Mental Wellness2025
  3. 3Insomnia: An Update on Epidemiology, Diagnosis and Non-pharmacological Management2024
  4. 4Redefining insomnia: from neural dysregulation to personalized therapeutics2025
  5. 5LIFESTYLE MODIFICATION, SLEEP HYGIENE AND PHARMACOTHERAPY OF CHRONIC INSOMNIA2026